EUVIMEDEUVIMED entdecken
Open Access

Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in KRAS - and BRAF -mutant cancer cells

Haibo Zhang iD, Abigail Read, Christophe Cataisson iD, Howard H Yang iD, Wei-Chun Lee, Benjamin E Turk iD, Stuart H Yuspa iD, Ji Luo iD

Science Signaling · 2024

DOI: 10.1126/scisignal.add5073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, 2024. Verfasst von Haibo Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, NF-kappa B, Proto-Oncogene Proteins p21(ras), MAP Kinase Signaling System. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Ras–mitogen-activated protein kinase (MAPK) pathway is a major target for cancer treatment. To better understand the genetic pathways that modulate cancer cell sensitivity to MAPK pathway inhibitors, we performed a CRISPR knockout screen with MAPK pathway inhibitors on a colorectal cancer (CRC) cell line carrying mutant KRAS. Genetic deletion of the catalytic subunit of protein phosphatase 6 (PP6), encoded by PPP6C , rendered KRAS - and BRAF -mutant CRC and BRAF -mutant melanoma cells more resistant to these inhibitors. In the absence of MAPK pathway inhibition, PPP6C deletion in CRC cells decreased cell proliferation in two-dimensional (2D) adherent cultures but accelerated the growth of tumor spheroids in 3D culture and tumor xenografts in vivo. PPP6C deletion enhanced the activation of nuclear factor κB (NF-κB) signaling in CRC and melanoma cells and circumvented the cell cycle arrest and decreased cyclin D1 abundance induced by MAPK pathway blockade in CRC cells. Inhibiting NF-κB activity by genetic and pharmacological means restored the sensitivity of PPP6C -deficient cells to MAPK pathway inhibition in CRC and melanoma cells in vitro and in CRC cells in vivo. Furthermore, a R264 point mutation in PPP6C conferred loss of function in CRC cells, phenocopying the enhanced NF-κB activation and resistance to MAPK pathway inhibition observed for PPP6C deletion. These findings demonstrate that PP6 constrains the growth of KRAS - and BRAF -mutant cancer cells, implicates the PP6–NF-κB axis as a modulator of MAPK pathway output, and presents a rationale for cotargeting the NF-κB pathway in PPP6C -mutant cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins B-rafNF-kappa BProto-Oncogene Proteins p21(ras)MAP Kinase Signaling SystemHumansAnimalsCell Line, TumorMutationMiceProtein Kinase InhibitorsCell ProliferationColorectal NeoplasmsMelanomaXenograft Model Antitumor AssaysDrug Resistance, NeoplasmMice, Nude

Substanzen

Proto-Oncogene Proteins B-rafNF-kappa BProto-Oncogene Proteins p21(ras)Protein Kinase Inhibitors

Autor:innen und Institutionen

  • Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.
  • Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA.

ORCID-Profile: Haibo Zhang, Christophe Cataisson, Howard H Yang, Benjamin E Turk, Stuart H Yuspa, Ji Luo

Förderung

  • Intramural NIH HHS

Zitieren

APA

Zhang, H., Read, A., Cataisson, C., Yang, H. H., Lee, W. C., Turk, B. E., Yuspa, S. H., & Luo, J. (2024). Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in KRAS - and BRAF -mutant cancer cells. Science Signaling. https://doi.org/10.1126/scisignal.add5073

Vancouver

Zhang H, Read A, Cataisson C, Yang HH, Lee WC, Turk BE, et al. Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in KRAS - and BRAF -mutant cancer cells. Science Signaling. 2024. doi:10.1126/scisignal.add5073

BibTeX
@article{Zhang2024,
  author = {Zhang, Haibo and Read, Abigail and Cataisson, Christophe and Yang, Howard H and Lee, Wei-Chun and Turk, Benjamin E and Yuspa, Stuart H and Luo, Ji},
  title = {Protein phosphatase 6 activates NF-κB to confer sensitivity to MAPK pathway inhibitors in KRAS - and BRAF -mutant cancer cells},
  journal = {Science Signaling},
  year = {2024},
  doi = {10.1126/scisignal.add5073}
}
Kostenlos starten →